U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT06938347) titled 'Comparing the Safety and Efficacy of ASI-02 to Agitated Saline for Suspected Right-to-left Shunt' on April 15.
Brief Summary: This is a phase 3, multicenter, open-label, blinded, crossover trial in which each participant will undergo a randomized sequence of ASI-02 and agitated saline standard of care (SoC) via a saline contrast transthoracic echocardiogram (TTE) study.
Study Start Date: May, 2025
Study Type: INTERVENTIONAL
Condition:
Right-To-Left Shunt
Intervention:
DRUG: Agitated Saline SoC
The recommended initial dose of agitated saline SoC is approximately 10 mL of saline containing approximately 1 mL of air, per instit...